Table 1.
Main characteristics of the 63 patients who had been reported to date with a pancreas plasmacytoma: Results of a PubMed search from 1950 to June 2016
| Demographic characteristics | n (%) |
| Male | 22 (56.4) |
| Age (years, median, IQR) | 58.5 [51.2-82] |
| Symptom(s) at diagnosis | |
| Jaundice | 35 (70.0) |
| Pain | 18 (36.0) |
| Myeloma | |
| Known history of myeloma | 26 (41.3) |
| Disease duration at diagnosis of pancreas plasmacytoma (years, median, IQR) | 1 [0-13] |
| Type Kappa | 13 (71.4) |
| Immunoglobulin | A (36%), G (52%), M (12%) |
| Diagnosis process of the pancreas plasmacytoma | |
| Endoscopic ultrasound FNA | 14 (32.6) |
| Percutaneous FNA | 9 (20.9) |
| Endoscopic biopsy | 7 (16.3) |
| Surgical biopsy | 11 (25.6) |
| Paracentesis | 0 (0.0) |
| Postmortem biopsy | 3 (7.0) |
| Management of the pancreas plasmacytoma | |
| Chemotherapy | 14 (56.0) |
| Radiotherapy | 13 (52.0) |
| Biliary stent in patients with jaundice | 10 (40.0) |
| Surgery | 8 (32.0) |
| Biliodigestive derivation | 3 (37.5) |
| Duodenopancreatectomy cephalic | 2 (25.0) |
FNA: Fine needle aspiration; IQR: Interquartile range.